Correction to Dipicolinic Acid Derivatives as ... - ACS Publications

Addition/Correction Cite This: J. Med. Chem. XXXX, XXX, XXX−XXX

pubs.acs.org/jmc

Correction to Dipicolinic Acid Derivatives as Inhibitors of New Delhi Metallo-β-lactamase‑1 Allie Y. Chen, Pei W. Thomas, Alesha C. Stewart, Alexander Bergstrom, Zishuo Cheng, Callie Miller, Christopher R. Bethel, Steven H. Marshall, Cy V. Credille, Christopher L. Riley, Richard C. Page, Robert A. Bonomo,* Michael W. Crowder,* David L. Tierney,* Walter Fast,* and Seth M. Cohen*

Downloaded via 188.68.0.226 on July 19, 2018 at 08:40:28 (UTC). See https://pubs.acs.org/sharingguidelines for options on how to legitimately share published articles.

Journal of Medicinal Chemistry 2017, 60, 7267−7283. DOI: 10.1021/acs.jmedchem.7b00407 Page 7270. In Scheme 1, the compound numbers are mislabeled. Compound 11 should be compound 1, compound 12 should be 2, and compounds 13−30 should be 3−20. The mislabel of the compounds in the scheme does not affect the main text or the results of this paper. The corrected Scheme 1 is shown here. Scheme 1. Synthetic Scheme for Sublibrary 1a

(a) MeOH, H2SO4 (cat.), 75 °C, 24 h, 100%; (b) MeOH, KOH, 0 °C, 4 h, 81%; (c) EDC, HOBT, H2NR, 18 h; then 4:1 1 M NaOH/ THF, 30 min to 1 h, 4 M HCl, 34−87%. a

© XXXX American Chemical Society

A

DOI: 10.1021/acs.jmedchem.8b01057 J. Med. Chem. XXXX, XXX, XXX−XXX